Background Excessive activation of immune responses in coronavirus disease 2019 (COVID-19)
is considered to be related to disease severity, complications, and mortality rate. The …

Complement C3 activation contributes to COVID-19 pathology, and C3 targeting has
emerged as a promising therapeutic strategy. We provide interim data from ITHACA, the first …

Multisystem inflammatory syndrome in children (MIS-C) is a rare, life-threatening complication
of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. MIS-C …

Background Infection with SARS-CoV-2 manifests itself as a mild respiratory tract infection in
the majority of individuals, which progresses to a severe pneumonia and acute respiratory …

Background: CD59, a broadly expressed glycosylphosphatidylinositol-anchored protein, is
the principal cell inhibitor of complement membrane attack on cells. In the demyelinating …

Introduction Various studies have reported the importance of complement regulators in
preventing mesothelial damage during peritoneal dialysis (PD). Its assessment, however, is …

Background Infection with SARS-CoV-2 manifests itself as a mild respiratory tract infection in
the majority of individuals, which progresses to a severe pneumonia and acute respiratory …

Peritoneal dialysis (PD) is an established form of renal replacement therapy. However, long-term
use is limited due to inherent complications such as peritonitis or fibrosis leading to …

Complement activation in the disease course of coronavirus disease 2019 and its effects on
clinical outcomes | Molecular Immunology; 141:150-151, 2022. | Web of Science Conteúdo …